Science Explorer Back to mapMap
Discussion
Company · Mutilva Baja · Spain

Geiser Pharma (Spain)

geiserpharma.comROR OpenAlex
Research works
5
▼ 50% vs 2018-21
Citations
114
21.4 per fractional work
Top-10% rate
11.1%
all institutions 10.0%
Open access
47%
world 40%
International
91%
world 18%
Geiser Pharma (Spain)

Not ranked overall: Geiser Pharma (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Geiser Pharma (Spain) work in?

In all years, 43% of research at Geiser Pharma (Spain) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (42%), Biochemistry, Genetics and Molecular Biology (20%), Agricultural and Biological Sciences (11%). It does 1.3× the world's share of Health Sciences.

Health Sciences: 2 fractional works · 43.3% of its workMedicine: 2 fractional works · 42.2% of its workReproductive Medicine: 1 fractional works · 19.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 12.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 4.1% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 2.1% of its workAnesthesiology and Pain Medicine: 0 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.5% of its workSurgery: 0 fractional works · 1.5% of its workHealth Professions: 0 fractional works · 1.1% of its workGeneral Health Professions: 0 fractional works · 1.1% of its workLife Sciences: 2 fractional works · 31.7% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 20.3% of its workPhysiology: 0 fractional works · 8.3% of its workMolecular Biology: 0 fractional works · 6.8% of its workGenetics: 0 fractional works · 5.3% of its workAgricultural and Biological Sciences: 1 fractional works · 11.4% of its workAgronomy and Crop Science: 0 fractional works · 3.6% of its workPlant Science: 0 fractional works · 3.2% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 1.5% of its workFood Science: 0 fractional works · 1.5% of its workInsect Science: 0 fractional works · 1.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 23.8% of its workEnvironmental Science: 1 fractional works · 9.9% of its workGlobal and Planetary Change: 0 fractional works · 4.1% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 3.2% of its workNature and Landscape Conservation: 0 fractional works · 2.6% of its workEngineering: 0 fractional works · 6.2% of its workBiomedical Engineering: 0 fractional works · 2.1% of its workComputational Mechanics: 0 fractional works · 2.1% of its workControl and Systems Engineering: 0 fractional works · 2.1% of its workMaterials Science: 0 fractional works · 4.1% of its workMaterials Chemistry: 0 fractional works · 4.1% of its workComputer Science: 0 fractional works · 2.1% of its workInformation Systems: 0 fractional works · 2.1% of its workEarth and Planetary Sciences: 0 fractional works · 1.5% of its workPaleontology: 0 fractional works · 1.5% of its workSocial Sciences: 0 fractional works · 1.1% of its workBusiness, Management and Accounting: 0 fractional works · 1.1% of its workManagement Information Systems: 0 fractional works · 1.1% of its workALL ITS WORKGeiser Pharma(Spain)5fractional works, all years
Life Sciences32%Physical Sciences24%Health Sciences43%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine242.2%
    2. Health Professions01.1%
    1. Biochemistry, Genetics and Molecular Biology120.3%
    2. Agricultural and Biological Sciences111.4%
    1. Environmental Science19.9%
    2. Engineering06.2%
    3. Materials Science04.1%
    4. Computer Science02.1%
    5. Earth and Planetary Sciences01.5%
    1. Business, Management and Accounting01.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Geiser Pharma (Spain)?

The most cited paper from Geiser Pharma (Spain) is "Oxidant-mediated lung injury in the acute respiratory distress syndrome" (Michael A. Matthay, Thomas Geiser, Sadis Matalon et al., 1999), with 62 citations. Next come "Effect of preoperative ejection fraction on survival and hemodynamic improvement following aortic valve replacement." (48) and "A conceptual framework of challenges and solutions for managing global software maintenance" (45).

Most cited papers
#PaperReleasedCitations
1 Oxidant-mediated lung injury in the acute respiratory distress syndrome Michael A. Matthay, Thomas Geiser, Sadis Matalon et al. · Critical Care Medicine Sep 1999 62
2 Effect of preoperative ejection fraction on survival and hemodynamic improvement following aortic valve replacement. J D O'Toole, Edward A. Geiser, P. SUDHAKAR REDDY et al. · Circulation Open access Dec 1978 48
3 A conceptual framework of challenges and solutions for managing global software maintenance Bayarbuyan Ulziit, Zeeshan Akhtar Warraich, Çiğdem Gencel et al. · Journal of Software Evolution and Process 21 Jun 2015 45
4 Effect of argan oil on liquid storage of ram semen in Tris or skim milk based extenders Larbi Allai, Xavier Druart, Jesús Contell et al. · Animal Reproduction Science 20 Jul 2015 40
5 Kinematic Sub-Populations in Bull Spermatozoa: A Comparison of Classical and Bayesian Approaches Luis Víquez, Vinicio Barquero, Carles Soler et al. · Biology Open access 26 Jun 2020 39
All 18 most cited papers, with filters and sorting

Which research topics does Geiser Pharma (Spain) publish most on?

By volume in 2022-now: Crystallization and Solubility Studies, Innovative Microfluidic and Catalytic Techniques Innovation, Male Reproductive Health Studies and Process Optimization and Integration.

Crystallization and Solu…0Crystallization and Solubility Studies: 0 fractional worksInnovative Microfluidic …0Innovative Microfluidic and Catalytic Techniques Innovation: 0 fractional worksMale Reproductive Health Studies: 0 fractional worksProcess Optimization and Integration: 0 fractional worksSperm and Testicular Fun…0Sperm and Testicular Function: 0 fractional worksForensic and Genetic Research: 0 fractional worksReproductive biology and impacts on aquatic species: 0 fractional worksGenetic and Clinical Asp…0Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities: 0 fractional worksProtein purification and stability: 0 fractional worksField-Flow Fractionation Techniques: 0 fractional works
Materials ChemistryBiomedical EngineeringGeneral Health ProfessionsControl and Systems Engineering5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Crystallization and Solubility Studies Materials Chemistry 0 works
  2. 2 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
  3. 3 Male Reproductive Health Studies General Health Professions 0 works
  4. 4 Process Optimization and Integration Control and Systems Engineering 0 works
  5. 5 Sperm and Testicular Function Reproductive Medicine 0 works
  6. 6 Forensic and Genetic Research Genetics 0 works
  7. 7 Reproductive biology and impacts on aquatic species Physiology 0 works
  8. 8 Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities Genetics 0 works
  9. 9 Protein purification and stability Molecular Biology 0 works
  10. 10 Field-Flow Fractionation Techniques Computational Mechanics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.9%not open53.1%

World: 40% of research is openly available.

with international co-authors90.6%domestic only9.4%

World: 18% is written across borders.

How has Geiser Pharma (Spain)'s research output changed?

Output in 2022-2025 was 50% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Geiser Pharma (Spain) as a percentage of every work published that year, 0.0000031% in 2023.

still counting0.000050%0.00010%0.00015%Geiser Pharma (Spain)0.000011% in 202519801990200020102020

Fractional works of Geiser Pharma (Spain) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Mutilva Baja

All research institutions in Mutilva Baja

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Geiser Pharma (Spain). Posts are plain text and can be reported.